| Literature DB >> 26149120 |
Xinjuan Xu1, Jiangfeng Mao2, Mingchen Zhang3, Haiming Liu1, Haixia Li1, Hong Lei1, Lu Han4, Min Gao1.
Abstract
BACKGROUND: Our study is aimed to 1) clarify the vitamin D status in Uygur and Kazak ethnic populations and 2) elucidate the relationship between 14 SNPs (in 5 vitamin D-related genes) and vitamin D deficiency in these 2 ethnic populations.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26149120 PMCID: PMC4501656 DOI: 10.12659/MSM.894793
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Characteristics of participants in two ethnic populations.
| Characteristics | Uygur ethnic (n=945) | Kazak ethnic (n=928) | |||
|---|---|---|---|---|---|
| M | (P25, P75) | M | (P25, P75) | ||
| Age (years) | 44.0 | (40.0, 55.0) | 47.0 | (39.0, 56.4) | 0.059 |
| Female (%) | 38.6 | 59.1 | 0.001 | ||
| BMI (Kg/m2) | 24.0 | (21.9, 27.3) | 27.5 | (24.4, 30.6) | <0.001 |
| Waist circumference (cm) | 86.1 | (77.0, 96.2) | 99 | (88.0, 107.0) | <0.001 |
| Systolic BP (mmHg) | 130.0 | (116.0, 140.0) | 139 | (125.0, 160.0) | <0.001 |
| Diastolic BP (mmHg) | 75.0 | (67.0,82.0) | 80 | (71.0, 90.0) | <0.001 |
| Hypertension (%) | 33.0 | 56.1 | 0.001 | ||
| Obesity (%) | 12.1 | 28.9 | 0.001 | ||
| 25OHD (ng/ml) | 10.4 | (6.5, 15.2) | 16.2 | (11.8, 20.5) | <0.001 |
| 25OHD deficiency (%) | 91.2 | 72.4 | 0.001 | ||
| 25OHD insufficiency (%) | 5.8 | 22.7 | |||
| 25OHD sufficiency (%) | 3.0 | 4.8 | |||
| Calcium (mmol/L) | 2.3 | (2.2, 2.4) | 2.3 | (2.2, 2.4) | 0.010 |
| Phosphate (mmol/L) | 1.2 | (1.0, 1.3) | 1.4 | (1.2, 1.5) | <0.001 |
| Alkaline phosphatase (U/L) | 81.5 | (70.5, 94.0) | 86 | (71.0, 105.0) | 0.075 |
| Fasting glucose (mmol/L) | 5.3 | (5.1, 5.7) | 4.9 | (4.5, 5.3) | <0.001 |
| Total cholesterol (mmol/L) | 4.1 | (3.4, 4.7) | 5.1 | (4.5, 5.8) | <0.001 |
| HDL cholesterol (mmol/L) | 1.0 | (0.8, 1.2) | 1.2 | (1.0, 1.5) | <0.001 |
| LDL cholesterol (mmol/L) | 2.6 | (2.2, 3.0) | 2.1 | (1.7. 2.5) | <0.001 |
| Triglycerides (mmol/L) | 1.4 | (0.9, 2.2) | 1.1 | (0.7, 1.5) | <0.001 |
| Urea nitrogen (mmol/L) | 4.7 | (4.0, 5.9) | 4.1 | (3.5, 5.0) | <0.001 |
| Serum creatinine (umol/L) | 62.1 | (51.0, 75.0) | 64 | (56.0, 74.0) | 0.045 |
P values were calculated from ANCOVA for continuous variables and Fisher’s exact test for categorical variables. For definitions of obesity, hypertension and vitamin D status, see Methods.
Allele frequencies in 14 SNPs by ethnicity.
| SNP | chr | Gene | Alleles | Uygur n=300 | Kazak n=300 | P | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| MAF | HET | HWE | MAF | HET | HWE | |||||
| rs7975232 | 12 | C/A | 0.42 | 0.52 | 0.40 | 0.42 | 0.36 | 0.77 | 0.972 | |
| rs731236 | 12 | G/A | 0.19 | 0.34 | 0.27 | 0.20 | 0.34 | 0.83 | 0.707 | |
| rs2239179 | 12 | C/T | 0.32 | 0.45 | 0.76 | 0.34 | 0.46 | 0.75 | 0.684 | |
| rs1544410 | 12 | G/A | 0.20 | 0.34 | 0.39 | 0.23 | 0.36 | 1.00 | 0.196 | |
| rs2228570 | 12 | G/A | 0.32 | 0.41 | 0.53 | 0.34 | 0.49 | 0.35 | 0.437 | |
| rs12717991 | 12 | C/T | 0.45 | 0.51 | 0.68 | 0.47 | 0.52 | 0.67 | 0.457 | |
| rs11168275 | 12 | C/T | 0.39 | 0.48 | 1.00 | 0.42 | 0.47 | 0.66 | 0.320 | |
| rs4588 | 4 | G/T | 0.22 | 0.36 | 0.85 | 0.26 | 0.36 | 0.27 | 0.202 | |
| rs2282679 | 4 | G/T | 0.23 | 0.37 | 0.70 | 0.26 | 0.35 | 0.15 | 0.263 | |
| rs7041 | 4 | C/A | 0.34 | 0.46 | 0.88 | 0.43 | 0.51 | 0.77 | ||
| rs10741657 | 11 | G/A | 0.43 | 0.56 | 0.40 | 0.50 | 0.56 | 0.365 | ||
| rs10766197 | 11 | G/A | 0.41 | 0.56 | 0.36 | 0.46 | 0.88 | 0.143 | ||
| rs10877012 | 12 | G/T | 0.37 | 0.42 | 0.88 | 0.47 | 0.48 | 0.67 | ||
| rs12785878 | 11 | G/T | 0.46 | 0.51 | 0.79 | 0.40 | 0.46 | 0.46 | 0.057 | |
Alleles – Allele major allele/minor allele; MAF – minor allele frequency. HWE P-values for Hardy-Weinberg Equilibrium test. P chi-square test of MAF between Uygur and Kazak ethnic group. Bold numbers represent significant P-values.
Allele distributions according to the status of vitamin D in Uygur and Kazak ethnics.
| SNP | Gene | Alleles | group | Uygur | Kazak | ||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 1 | 2 | ||||||
| rs7975232 | C/A | Case | 0.58 | 0.42 | 0.77 | 0.59 | 0.41 | 0.40 | |
| Control | 0.59 | 0.41 | 0.56 | 0.44 | |||||
| rs731236 | G/A | Case | 0.80 | 0.20 | 0.83 | 0.81 | 0.19 | 0.27 | |
| Control | 0.78 | 0.22 | 0.79 | 0.21 | |||||
| rs2239179 | C/T | Case | 0.66 | 0.34 | 0.75 | 0.66 | 0.34 | 0.76 | |
| Control | 0.69 | 0.31 | 0.71 | 0.29 | |||||
| rs1544410 | G/A | Case | 0.77 | 0.23 | 1.00 | 0.81 | 0.19 | 0.39 | |
| Control | 0.78 | 0.22 | 0.79 | 0.21 | |||||
| rs2228570 | G/A | Case | 0.66 | 0.34 | 0.35 | 0.69 | 0.31 | 0.53 | |
| Control | 0.66 | 0.34 | 0.67 | 0.33 | |||||
| rs12717991 | C/T | Case | 0.52 | 0.48 | 0.67 | 0.55 | 0.45 | 0.68 | |
| Control | 0.56 | 0.44 | 0.56 | 0.44 | |||||
| rs11168275 | C/T | Case | 0.58 | 0.47 | 0.66 | 0.64 | 0.36 | 0.56 | |
| Control | 0.53 | 0.47 | 0.57 | 0.43 | |||||
| rs4588 | G/T | Case | 0.73 | 0.27 | 0.27 | 0.76 | 0.24 | 0.85 | |
| Control | 0.88 | 0.12 | 0.80 | 0.20 | |||||
| rs2282679 | G/T | Case | 0.72 | 0.28 | 0.15 | 0.75 | 0.25 | 0.70 | |
| Control | 0.88 | 0.12 | 0.80 | 0.20 | |||||
| rs7041 | C/A | Case | 0.58 | 0.42 | 0.77 | 0.66 | 0.34 | 0.88 | |
| Control | 0.41 | 0.59 | 0.65 | 0.35 | |||||
| rs10741657 | G/A | Case | 0.61 | 0.39 | 0.56 | 0.58 | 0.42 | 0.05 | |
| Control | 0.53 | 0.47 | 0.56 | 0.44 | |||||
| rs10766197 | G/A | Case | 0.63 | 0.37 | 0.88 | 0.57 | 0.43 | 0.62 | |
| Control | 0.75 | 0.25 | 0.62 | 0.38 | |||||
| rs10877012 | G/T | Case | 0.52 | 0.48 | 0.77 | 0.64 | 0.30 | 0.88 | |
| Control | 0.62 | 0.38 | 0.62 | 0.38 | |||||
| rs12785878 | G/T | Case | 0.60 | 0.40 | 0.46 | 0.50 | 0.50 | 0.79 | |
| Control | 0.66 | 0.34 | 0.61 | 0.39 | |||||
The major allele was referred to as allele 1 and the minor allele as allele 2.
The p-value of alleles was calculated using Fisher’s exact test to compare the participants with vitamin D deficiency and those without in the same ethnic population. Vitamin D deficiency was defined as serum 25OHD <20 ng/ml. Case: participant with vitamin D deficiency, control: participant without vitamin D deficiency.
Genotype frequencies according to the status of vitamin D in Uygur and Kazak ethnics.
| SNP | Gene | Alleles | Group | Uygur | Kazak | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11 | 12 | 22 | OR | P | 11 | 12 | 22 | OR | P | ||||
| rs7975232 | VDR | C/A | Case | 0.35 | 0.46 | 0.19 | 0.685 (0.209–2.246) | 0.532 | 0.35 | 0.47 | 0.18 | 0.515 (0.258–1.029) | 0.060 |
| Control | 0.31 | 0.56 | 0.13 | 0.25 | 0.62 | 0.13 | |||||||
| rs731236 | VDR | G/A | Case | 0.64 | 0.34 | 0.02 | 0.948 (0.289–3.108) | 0.930 | 0.64 | 0.34 | 0.02 | 1.036 (0.548–1.957) | 0.914 |
| Control | 0.63 | 0.31 | 0.06 | 0.64 | 0.32 | 0.04 | |||||||
| rs2239179 | VDR | C/T | Case | 0.44 | 0.47 | 0.09 | 1.379 (0.440–4.322) | 0.581 | 0.42 | 0.48 | 0.10 | 1.743 (0.928–3.273) | 0.084 |
| Control | 0.50 | 0.38 | 0.12 | 0.53 | 0.37 | 0.10 | |||||||
| rs1544410 | VDR | G/A | Case | 0.59 | 0.36 | 0.05 | 1.151 (0.354–3.747) | 0.815 | 0.64 | 0.34 | 0.02 | 1.080 (0.571–2.044) | 0.812 |
| Control | 0.63 | 0.31 | 0.06 | 0.64 | 0.32 | 0.04 | |||||||
| rs2228570 | VDR | G/A | Case | 0.42 | 0.47 | 0.11 | 0.442 (0.139–1.406) | 0.167 | 0.47 | 0.43 | 0.10 | 1.270 (0.672–2.399) | 0.462 |
| Control | 0.31 | 0.69 | 0.00 | 0.48 | 0.37 | 0.15 | |||||||
| rs12717991 | VDR | C/T | Case | 0.27 | 0.53 | 0.20 | 2.251 (0.651–7.781) | 0.200 | 0.28 | 0.54 | 0.18 | 1.370 (0.696–2.696) | 0.362 |
| Control | 0.38 | 0.38 | 0.24 | 0.32 | 0.47 | 0.21 | |||||||
| rs11168275 | VDR | C/T | Case | 0.35 | 0.47 | 0.18 | 0.787 (0.230–2.700) | 0.704 | 0.42 | 0.44 | 0.14 | 0.535 (0.273–1.045) | 0.067 |
| Control | 0.31 | 0.44 | 0.25 | 0.30 | 0.54 | 0.16 | |||||||
| rs4588 | GC | G/T | Case | 0.55 | 0.37 | 0.08 | 1.60 (0.45–5.62) | 0.465 | 0.57 | 0.39 | 0.04 | 1.511 (0.789–2.893) | 0.213 |
| Control | 0.75 | 0.25 | 0.00 | 0.66 | 0.28 | 0.06 | |||||||
| rs2282679 | GC | G/T | Case | 0.55 | 0.36 | 0.09 | 1.590 (0.453–5.588) | 0.469 | 0.55 | 0.41 | 0.04 | 1.657 (0.865–3.173) | 0.128 |
| Control | 0.75 | 0.25 | 0.00 | 0.66 | 0.28 | 0.06 | |||||||
| rs7041 | GC | C/A | Case | 0.32 | 0.53 | 0.15 | 1.812 (0.446–7.367) | 0.406 | 0.44 | 0.44 | 0.12 | 0.808 (0.430–1.518) | 0.507 |
| Control | 0.25 | 0.31 | 0.44 | 0.40 | 0.50 | 0.10 | |||||||
| rs10741657 | CYP2R1 | G/A | Case | 0.37 | 0.50 | 0.13 | 0.648 (0.184–2.291) | 0.501 | 0.31 | 0.54 | 0.15 | 0.710 (0.358–1.408) | 0.327 |
| Control | 0.25 | 0.56 | 0.19 | 0.25 | 0.62 | 0.13 | |||||||
| rs10766197 | CYP2R1 | G/A | Case | 0.39 | 0.48 | 0.13 | 0.32 | 0.51 | 0.17 | 0.786 (0.405–1.526) | 0.476 | ||
| Control | 0.69 | 0.12 | 0.19 | 0.30 | 0.64 | 0.06 | |||||||
| rs10877012 | CYP27B1 | G/T | Case | 0.30 | 0.46 | 0.24 | 0.870 (0.267–2.836) | 0.818 | 0.42 | 0.44 | 0.14 | 0.689 (0.360–1.318) | 0.260 |
| Control | 0.31 | 0.63 | 0.06 | 0.35 | 0.53 | 0.12 | |||||||
| rs12785878 | DHCR7/NADSYN1 | G/T | Case | 0.38 | 0.44 | 0.18 | 0.903 (0.293–2.784) | 0.859 | 0.23 | 0.55 | 0.22 | ||
| Control | 0.38 | 0.56 | 0.06 | 0.39 | 0.43 | 0.18 | |||||||
OR – odds ratio, 95%CI – 95% confidence intervals.
The major allele was referred to as allele 1 and the minor allele as allele 2.
The p-value of alleles was calculated using Fisher’s exact test to compare the participants with vitamin D deficiency and those without.
OR estimated by logistic regression analysis, adjusted for gender, age, BMI and study site. Bold numbers represent significant P-values. Vitamin D deficiency was defined as serum 25OHD <20 ng/ml. Case: participant with vitamin D deficiency, control: participant without vitamin D deficiency.